Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
VRAX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.84M
- EPS (TTM)
- -$13.40
- Dividend yield
- None
- 52-week range
- 1.83 – 21.75
- Day range
- 1.83 – 2.18
- Volume / Avg
- 265.35K / 1.80M
- Beta
- —
- Shares outstanding
- 1.34M
52-week range
VRAX stock today
Shares of Virax Biolabs Group (VRAX) finished higher on Oct 7 at $2.11, a gain of 3.94% or $0.08 per share, versus the S&P 500's 0.22% decline. Trading was light, with 265.35K shares changing hands, about 15% of the average daily volume. Shares are 90.3% below their 52-week high of $21.75 and 15.3% above the 52-week low of $1.83, near the bottom of the past year's range.
Virax Biolabs Group has posted a net loss over the last twelve months (EPS of -$13.40), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Virax Biolabs Group
Company profile- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IPO year
- 2022
Virax Biolabs Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| QCLSQ/C Technologies Inc. | 0.632 | -8.42% | $5.18M | vs VRAX |
| TRIBTrinity Biotech plc ADR | 6.75 | -5.59% | $5.49M | vs VRAX |
| CDIOCardio Diagnostics Holdings Inc. | 1.96 | -2.00% | $5.80M | vs VRAX |
| VNRXVolitionRX Limited | 0.226 | -6.96% | $6.79M | vs VRAX |
| BMRABiomerica Inc. | 1.91 | -10.75% | $8.78M | vs VRAX |
| ICCCImmuCell Corporation | 9.69 | -2.81% | $88.01M | vs VRAX |
| IMDXInsight Molecular Diagnostics Inc. | 3.46 | +2.37% | $113.23M | vs VRAX |
| NTLAIntellia Therapeutics Inc. | 11.71 | -5.34% | $1.64B | vs VRAX |
Indexes, lists and sector
Virax Biolabs Group stock FAQ
What is Virax Biolabs Group's stock price today?
VRAX last traded at $2.11 as of Oct 7, 4:00 PM EDT, up 3.94% on the day. Prices are delayed at least 15 minutes.
What is the VRAX 52-week high?
The 52-week high for VRAX is $21.75 and the 52-week low is $1.83. The stock is currently 90.3% below its high.